Buspirone, lofexidine, or placebo during opioid withdrawal
About this title
Evaluating Buspirone to Treat Opioid Withdrawal
Read the official source — NCT05511909Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid Withdrawal
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Evaluating Buspirone to Treat Opioid Withdrawal
Read the official source — NCT05511909Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Opioid Withdrawal
Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
Read the official source — NCT06593652Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
Evaluating Conversational Artificial Intelligence for Depression Management
Read the official source — NCT07105397Evaluating Conversational Artificial Intelligence for Depression Management
Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD
Read the official source — NCT07614867Group-based Emotion Regulation Skills Training for Adults With ADHD: GEARS, a Quantitative and Qualitative Investigation of Treatment Effects
Evaluating Evidenced Based Options for PTSD Treatment
Read the official source — NCT06733376Evaluating Evidence Based Options for Initial PTSD Treatment Non-Responders
Evaluating Interventions for Intimate Partner Violence Use in Washington State
Read the official source — NCT06526247Evaluating Interventions for Intimate Partner Violence Use in Washington State
Evaluating the atittudes of Australian psychologists, psychiatrists and mental health researchers towards 3,4-Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for the treatment of PTSD: A double-blind, randomised controlled trial
Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications.
Read the official source — NCT06617949Evaluating Pain Control Strategies in Postpartum Patients on Opioid Use Disorder Medications: Efficacy and Safety Outcomes.
Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
Read the official source — NCT06551038Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
Read the official source — NCT06504290A Phase I Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VV119 Capsules With Multiple Ascending Doses in Chinese Healthy Adult Subjects and Patients With Schizophrenia
Evaluating Screening Adherence Between Moment for Parents App and Attention Control
Read the official source — NCT07322042Evaluating Screening Adherence Between Moment for Parents App and Attention Control
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
Read the official source — NCT06278922Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.